Health care utilization in multiple sclerosis: a population-based study in Olmsted County, MN

Neurology
K A Stolp-SmithM Rodriguez

Abstract

The authors sought to determine acute ambulatory- and hospital-billed charges for the Olmsted County, Minnesota Multiple Sclerosis (MS) Disability Prevalence Cohort and compare them to those incurred by the general population. Billed charges for 155 people with clinically definite or laboratory-supported MS were compared with those of age- and gender-matched non-MS controls. Billing data, including all inpatient and outpatient acute and rehabilitative medical care charges over a 5-year period surrounding a December 1, 1991 prevalence date, were analyzed. Data were correlated with level of disability using the Minimal Record of Disability for MS. Median total annual billed charges for most individuals with MS, including those with less severe ($1,277) and relapsing-remitting illness ($1,348), did not differ from those for controls ($1,327, p=0.075). Only those with severe MS (22.6%) had median annual medical charges higher than controls ($5,440, p < 0.001). Male patients with MS had higher median annual total charges ($2,353) than male controls ($762, p=0.003). Total charges for female patients with MS ($1,440) were not different from those for female controls ($1469). Median annual outpatient charges were 15% more for the MS gr...Continue Reading

Citations

Apr 13, 2006·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Fary KhanTrevor Kilpatrick
Nov 18, 2000·Journal of Neurology, Neurosurgery, and Psychiatry·J A Freeman, A J Thompson
Aug 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·C PozzilliM Battaglia
Jan 1, 2009·ClinicoEconomics and Outcomes Research : CEOR·Ceri J Phillips, Ioan Humphreys
Apr 21, 2010·PharmacoEconomics·Huseyin NaciAmy Duhig
Jan 23, 2014·BMC Health Services Research·Oana DanilaNathalie Jetté
Jun 15, 2013·Multiple Sclerosis International·Sanober NusratKlaus Bielefeldt
Jun 30, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Sheri L PoharKenneth Warren
Dec 2, 2010·Women's Health·Céline JobinPierre Duquette
Jan 11, 2002·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C LamplB Pesec
Dec 23, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E OrlewskaA Czlonkowska
Jun 28, 2000·Current Opinion in Neurology·M G Clanet, D Brassat
Jan 1, 2004·Occupational Therapy in Health Care·Marcia FinlaysonEynat Shevil
Apr 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Ewa Orlewska
Feb 5, 2015·Acta Neurologica Scandinavica·Guillermo IzquierdoGuillermo Navarro
Feb 18, 2004·The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association·Robert J BuchananMyungSuk Kim
Jul 22, 2015·Multiple Sclerosis and Related Disorders·Ruth Ann MarrieAllan Garland
Sep 16, 2004·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lisa A ProsserMilton C Weinstein
Apr 17, 2015·Multiple Sclerosis and Related Disorders·Jonathan D CampbellKavita Nair
Jul 28, 2001·Multiple Sclerosis : Clinical and Laboratory Research·R J BuchananD Graber
Jun 25, 2008·Multiple Sclerosis : Clinical and Laboratory Research·K GottbergL Widén Holmqvist
Dec 12, 2002·Multiple Sclerosis : Clinical and Laboratory Research·R J BuchananH Ju
Feb 6, 2004·Multiple Sclerosis : Clinical and Laboratory Research·Robert J BuchananHyunsu Ju
Mar 30, 2005·Multiple Sclerosis : Clinical and Laboratory Research·M B PatwardhanT T Li
Dec 9, 2004·Multiple Sclerosis : Clinical and Laboratory Research·Robert J BuchananMyungSuk Kim
May 16, 2019·PloS One·Maryam S AlowayeshRaed Alroughani
Feb 24, 2004·Revue neurologique·J GrimaudUNKNOWN Collectif SEP des villes et SEP des champs
Sep 29, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Dirk SchrieferTjalf Ziemssen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Australian Health Review : a Publication of the Australian Hospital Association
Michael K Walsh
Canadian Journal on Aging = La Revue Canadienne Du Vieillissement
Ashli Watt, Candace Konnert
Journal of Clinical Pharmacy and Therapeutics
D A Francis
© 2022 Meta ULC. All rights reserved